We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Ananda Pharama PLC (ANA) ORD GBP0.002

Sell:0.40p Buy:0.45p Change: 0.045p (10.59%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Sell:0.40p
Buy:0.45p
Change: 0.045p (10.59%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
Sell:0.40p
Buy:0.45p
Change: 0.045p (10.59%)
Market closed |  Prices as at close on 24 December 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Ananda Pharma plc, formerly Ananda Developments plc, is a United Kingdom-based pharmaceutical company. The Company is focused on the research and development of cannabidiol (CBD)-based therapies. It is engaged in developing medicines for the treatment of drug-resistant epilepsies and specific inflammatory pain conditions (starting with chemotherapy induced peripheral neuropathy (CIPN) & endometriosis) and Heart Failure with preserved Ejection Fraction (HFpEF). ACTiON is a Phase II, double blind placebo-controlled crossover randomized clinical trial (RCT) to assess its MRX1 drug candidate versus placebo in the treatment of CIPN. ENDOCAN-1 shall help determining whether a cannabinoid can reduce endometriosis-associated pain. HFpEF is a study designed to evaluate the cardioprotective effects of its MRX1 drug candidate in a preclinical HFpEF model. Its two novel cannabinoid medicines: MRX2 (CBD) and MRX2T, helps in a range of seizure types and epilepsies in children and adults.

Contact details

Address:
6th Fl
Allianz House, 60 Gracechurch Street
LONDON
EC3V 0HR
United Kingdom
Telephone:
+ (0)
Website:
https://anandadevelopments.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

EPIC:
ANA
ISIN:
GB00BDQPXQ60
Market cap:
£18.70 million
Shares in issue:
2.88 billion
Sector:
Pharmaceuticals
Exchange:
-
Currency:
Sterling pence
Indices:
n/a

Key personnel


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.